ArticleCell discovery2022

CoVac501, a self-adjuvanting peptide vaccine conjugated with TLR7 agonists, against SARS-CoV-2 induces protective immunity.

Yiru Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.